Explore groundbreaking studies, reviews, and discoveries in ubiquitination pathways
Discover how QLS1209, a novel PKMYT1 inhibitor, is revolutionizing cancer treatment through synthetic lethality targeting CCNE1-amplified and FBXW7-mutated tumors.